...
首页> 外文期刊>EMBO reports >Loss of intestinal crypt progenitor cells owing to inactivation of both Notch1 and Notch2 is accompanied by derepression of CDK inhibitors p27(Kip1) and p57(Kip2)
【24h】

Loss of intestinal crypt progenitor cells owing to inactivation of both Notch1 and Notch2 is accompanied by derepression of CDK inhibitors p27(Kip1) and p57(Kip2)

机译:由于Notch1和Notch2均失活,导致肠道隐窝祖细胞丢失,同时伴有CDK抑制剂p27(Kip1)和p57(Kip2)抑制。

获取原文
获取原文并翻译 | 示例

摘要

The crucial role of individual Notch receptors and the mechanism by which they maintain intestinal crypt progenitor cells were assessed by using a series of inducible gut-specific Notch mutant mice. We found that Notch1 and Notch2 receptors function redundantly in the gut, as only simultaneous loss of both receptors results in complete conversion of proliferating crypt progenitors into post-mitotic goblet cells. This conversion correlates with the loss of Hes1 expression and derepression of the cyclin-dependent kinase (CDK) inhibitors p27(Kip1) and p57(Kip2). We also found that the promoter of both CDK inhibitor genes is occupied by the Notch effector Hes1 in wild-type crypt progenitor cells. Thus, our results indicate that Notch-mediated Hes1 expression contributes to the maintenance of the proliferative crypt compartment of the small intestine by transcriptionally repressing two CDK inhibitors.
机译:通过使用一系列诱导型肠道特异性Notch突变小鼠,评估了各个Notch受体的关键作用及其维持肠道隐窝祖细胞的机制。我们发现,Notch1和Notch2受体在肠道中冗余发挥作用,因为仅这两种受体的同时丢失会导致增殖的隐窝祖细胞完全转化为有丝分裂后的杯状细胞。这种转换与Hes1表达的丧失和细胞周期蛋白依赖性激酶(CDK)抑制剂p27(Kip1)和p57(Kip2)的抑制相关。我们还发现,两种CDK抑制剂基因的启动子在野生型隐窝祖细胞中被Notch效应子Hes1占据。因此,我们的结果表明,Notch介导的Hes1表达通过转录抑制两种CDK抑制剂而有助于维持小肠的增殖窝。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号